Pezzi, Julio Carlos; Dantas, Giovana; Hidalgo, Maria Paz Loayza; Grassi-Oliveira, Rodrigo; Markus, Regina P 
Fonte: Biological Psychiatry. Nome do evento: Annual Scientific Convention and Meeting. Unidade: IB
Assuntos: DEPRESSÃO, ANTIDEPRESSIVOS, MELATONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZZI, Julio Carlos et al. 6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake. Biological Psychiatry. Philadelphia: Instituto de Biociências, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2011APA
Pezzi, J. C., Dantas, G., Hidalgo, M. P. L., Grassi-Oliveira, R., & Markus, R. P. (2011). 6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake. Biological Psychiatry. Philadelphia: Instituto de Biociências, Universidade de São Paulo.NLM
Pezzi JC, Dantas G, Hidalgo MPL, Grassi-Oliveira R, Markus RP. 6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake. Biological Psychiatry. 2011 ; 69( 9 suppl.): 1345 res. 450.[citado 2024 nov. 04 ]Vancouver
Pezzi JC, Dantas G, Hidalgo MPL, Grassi-Oliveira R, Markus RP. 6-Sulfatoximelatonin as a predictor of clinical outcome in depressive patients treated with inhibitors of monoamine uptake. Biological Psychiatry. 2011 ; 69( 9 suppl.): 1345 res. 450.[citado 2024 nov. 04 ]
